- Article
Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice
- Laura P. Stabile,
- Mary E. Rothstein,
- Phouthone Keohavong,
- Diana Lenzner,
- Stephanie R. Land,
- Autumn L. Gaither-Davis,
- K. Jin Kim,
- Naftali Kaminski and
- Jill M. Siegfried
EGFR and c-Met are both overexpressed in lung cancer and initiate similar downstream signaling, which may be redundant. To determine how frequently ligands that initiate signaling of both pathways are found in lung cancer, we analyzed serum for hepat...

